A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

NCT02289027 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Ebola Vaccines

Interventions

BIOLOGICAL: cAd3-EBOZ vaccine
BIOLOGICAL: Placebo (for cAd3-EBOZ vaccine)

Sponsor

Centre Hospitalier Universitaire Vaudois

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]